Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Consolidates and expands study locations by replacing multiple 'X Locations' subsections with a unified 'Locations' section listing many regions (e.g., Arizona, California, Ontario, Emilia-Romagna, etc.). Prior location groupings such as 'Arizona Locations' and 'California Locations' were removed to reflect the new structure.
    Difference
    1%
    Check dated 2025-12-24T15:45:06.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically populated and may not pertain to this study. Updated the revision tag to v3.3.2 and replaced the previous PubMed description (v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-25T21:15:16.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Notice about the government funding lapse banner on the NIH/ClinicalTrials.gov page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T19:05:54.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page content appears unchanged between the two screenshots; there are no added or removed sections in the study details, eligibility criteria, or locations.
    Difference
    0.2%
    Check dated 2025-10-28T02:16:54.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T15:49:56.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) that were present under v3.0.2. This indicates a content pruning and version update rather than adding new core information.
    Difference
    0.2%
    Check dated 2025-09-29T09:47:19.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.